Merck & Co., Inc. is a global research-driven pharmaceutical company dedicated to putting patients first.

Patients & Caregivers

Healthcare Professionals - Opens new window

Worldwide - Opens new window

Quick Find - Click to open on a page

Merck Pipeline

Merck Patient Assistant Programs

NYSE | MRK 27.0100 | -1.0400

4:33 PM ET | 02 Jul 2009

Product News: Read the latest news on Merck medicines and vaccines
Research & Development News: Read the latest news on Merck Research and Development
Corporate News: Merck and Schering-Plough Receive Request for Additional Information from FTC Regarding Proposed Merger
Financial News: Merck Prices $4.25 Billion Debt Offering
Corporate Responsibility News: Nation's Top 37 Minority Students Awarded Prestigious UNCF/MERCK Science Scholarships & Fellowships

Find out what Merck is doing on Health Care Reform in the U.S.
Health Reform Meeting with President Obama

SINGULAIR® (montelukast sodium)
Response to FDA's update regarding a safety review of SINGULAIR

GARDASIL® [Human Papillomavirus Quadrivalent (Types 6, 11, 16, 18) Vaccine, Recombinant
Merck Responds to Questions about Adverse Events Reported

FOSAMAX® (alendronate sodium)
Statement regarding Osteonecrosis of the Jaw

This U.S. Web site is subject to Merck.com Terms of Use

*Software to view files presented in PDF or SWF format is available at no charge
through the Adobe Web site. Get Adobe Reader Get Adobe Flash Player

RSS